Incorporating CA19-9 testing in a prospective study of pancreatic cancer surveillance (PCS) among high-risk individuals (HRIs).
Isabelle Flaherty, Asaf Maoz, Michael H. Rosenthal, Miki Horiguchi et al.
Journal
Journal of Clinical Oncology
Topics
Pancreatic and Hepatic Oncology Research
article
Incorporating CA19-9 testing in a prospective study of pancreatic cancer surveillance (PCS) among high-risk individuals (HRIs).
Isabelle Flaherty, Asaf Maoz, Michael H. Rosenthal, Miki Horiguchi, Sapna Syngal, Samantha Kuney, James R. Eshleman, Emy Abou Sleiman, Chinedu Ukaegbu, Vidya Madineedi, Matthew B. Yurgelun, Benjamin MacKinnon, Michael Goggins, Alyson Caruso, Brian M. Wolpin, Lauren K. Brais, Leah Biller
article en
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 44(16_suppl)
Institutions
Harvard University (US), Johns Hopkins University (US), Johns Hopkins Medicine (US), Dana-Farber Cancer Institute (US), Sidney Kimmel Comprehensive Cancer Center (US), Mass General Brigham (US)